Abstract

Thesis

Impact of Thin Endometrium in Frozen Embryo Transfer: Thesis Summary Article

Sakthi A*

Published: 13 June, 2025 | Volume 8 - Issue 2 | Pages: 037-056

Background: Endometrial Thickness (EMT) is considered an important prognostic factor in assisted reproductive technology (ART), particularly in frozen embryo transfer (FET) cycles. Thin endometrium (< 7 mm) is often associated with implantation failure and reduced pregnancy rates, although its precise impact remains controversial.
Objective: This thesis summary evaluates the role of thin endometrium in FET cycles, discusses etiologies, diagnostic modalities, treatment approaches, and reviews available patient data.
Methods: We retrospectively analyzed 69 patients who underwent FET at Saveetha Medical College. Endometrial thickness was assessed via transvaginal ultrasound. Various treatment strategies including hormonal therapies (estradiol, progesterone), vasoactive agents, granulocyte colony-stimulating factor (G-CSF), platelet-rich plasma (PRP), L-arginine, sildenafil citrate, vitamin E, pentoxifylline, and stem cell therapy were reviewed for their efficacy in improving endometrial receptivity.
Results: Endometrial thickness < 7 mm correlated with lower pregnancy rates compared to patients with thickness ≥ 7 mm. Hormonal and adjuvant therapies reported varying degrees of success in improving EMT and subsequent pregnancy outcomes. Vascularity, angiogenesis, and Doppler studies also demonstrated a significant association with endometrial receptivity.
Conclusion: Thin endometrium remains a critical challenge in ART cycles. Multimodal therapeutic approaches may improve outcomes; however, larger prospective studies are required to establish standardized protocols. Our patient data support that even minimal increases in EMT can enhance implantation success.

Read Full Article HTML DOI: Cite this Article Read Full Article PDF

Keywords:

Thin Endometrium; Frozen Embryo Transfer (FET); Endometrial Thickness (EMT); Endometrial Receptivity; Assisted Reproductive Technology (ART); Platelet-Rich Plasma (PRP); Granulocyte Colony Stimulating Factor (G-CSF); Angiogenesis

References

  1. Jaffe R, Warsof SL. Transvaginal color Doppler imaging in the assessment of uteroplacental blood flow in the normal first-trimester pregnancy. Am J Obstet Gynecol. 1992;164:781–785. Available from: https://doi.org/10.1016/0002-9378(91)90515-s
  2. Chien LW, Au HK, Chen PL, Tzeng CR. Assessment of uterine receptivity by the endometrial-subendometrial blood flow distribution pattern in women undergoing in-vitro fertilization embryo transfer. Fertil Steril. 2002;78:245–251. Available from: https://doi.org/10.1016/s0015-0282(02)03223-5
  3. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975;122:262–263. Available from: https://doi.org/10.1016/s0002-9378(16)33500-1
  4. Dickey RP, Olar TT, Taylor SN, Curole DN, Rye PH, Matulich EM. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: Effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril. 1993;59:756–760. Available from: https://doi.org/10.1016/s0015-0282(16)55855-5
  5. Schild RL, Knobloch C, Dorn C, Fimmers R, van der Ven H, Hansmann M. Endometrial receptivity in-vitro fertilization program assessed by spiral artery blood flow, endometrial thickness, endometrial volume and uterine artery blood flow. Fertil Steril. 2001;7:361–366. Available from: https://doi.org/10.1016/s0015-0282(00)01695-2
  6. Dominguez F, Remohi J, Pellecer A, Simón C. Human endometrial receptivity: a genomic approach. Reprod Biomed Oneline. 2003;6:332–338. Available from: https://doi.org/10.1016/s1472-6483(10)61853-6
  7. El-Toukhy T, Coomarasamy A, Khairy M, Sunkara K, Seed P, Khalaf Y, et al. The relationship between endometrial thickness and outcome of medicated frozen embryo replacement cycles. Fertil Steril. 2008;89(4):832-839. Available from: https://doi.org/10.1016/j.fertnstert.2007.04.031
  8. Glissant A, de Mouzon J, Frydman R. Ultrasound study of the endometrium during in vitro fertilization cycles. Fertil Steril. 1985;44(6):786-790. Available from: https://doi.org/10.1016/s0015-0282(16)49038-2
  9. Mahajan N, Sharma S. The endometrium in assisted reproductive technology: how thin is thin? J Hum Reprod Sci. 2016;9(1):3-8. Available from: https://doi.org/10.4103/0974-1208.178632
  10. Miwa I, Tamura H, Takasaki A, Yamagata Y, Shimamura K, Sugino N. Pathophysiologic features of “thin” endometrium. Fertil Steril. 2009;91(4):998-1004. Available from: https://doi.org/10.1016/j.fertnstert.2008.01.029
  11. Senturk C, Erel T. Thin endometrium in assisted reproductive technology. Curr Opin Obstet Gynecol. 2008;20(3):221-228. Available from: https://doi.org/10.1097/gco.0b013e328302143c
  12. Dain L, Bider D, Levron J, Zinchenko V, Westler S, Dirnfeld M. Thin endometrium in donor oocyte recipients: Enigma or obstacle for implantation? Fertil Steril. 2013;100:1289–95. Available from: https://doi.org/10.1016/j.fertnstert.2013.07.1966
  13. Strohmer H, Obruca A, Radner KM, Feichtinger W. Relationship of the individual uterine size and the endometrial thickness in stimulated cycles. Fertil Steril. 1994;61:972–5. Available from: https://doi.org/10.1016/s0015-0282(16)56716-8
  14. Scioscia M, Lamanna G, Lorusso F, Serrati G, Selvaggi LE, Depalo R. Characterization of endometrial growth in proliferative and early luteal phase in IVF cycles. Reprod Biomed Online. 2009;18(1):73-78. Available from: https://doi.org/10.1016/s1472-6483(10)60427-0
  15. Gonen Y, Casper RF, Jacobson W, Blankier J. Endometrial thickness and growth during ovarian stimulation: a possible predictor of implantation in in vitro fertilization. Fertil Steril. 1989;52(3):446-450. Available from: https://doi.org/10.1016/s0015-0282(16)60916-0
  16. Barker MA, Boehnlein LM, Kovacs P, Lindheim SR. Follicular and luteal phase endometrial thickness and echogenic pattern and pregnancy outcome in oocyte donation cycles. J Assist Reprod Genet. 2009;26:243–9. Available from: https://doi.org/10.1007/s10815-009-9312-z
  17. Mercé LT, Barco MJ, Bau S, Troyano J. Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in-vitro fertilization/embryo transfer outcome? Fertil Steril. 2008;89:111–117. Available from: https://doi.org/10.1016/j.fertnstert.2007.02.029
  18. De Geyter C, Schmitter M, De Geyter M, Nieschlag E, Holzgreve W, Schneider HP. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril. 2000;73(1):106-113. Available from: https://doi.org/10.1016/s0015-0282(99)00484-7
  19. Friedler S, Schenker JG, Herman A, Lewin A. The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod Update. 1996;2(4):323-335. Available from: https://doi.org/10.1093/humupd/2.4.323
  20. Glujovsky D, Pesce R, Sueldo C, Quinteiro Retamar AM, Hart RJ, Ciapponi A. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev. 2020 Oct 28;10(10):CD006359. Available from: https://doi.org/10.1002/14651858.cd006359.pub3
  21. Grunfeld L, Walker B, Bergh PA, Sandler B, Hofmann G, Navot D. High-resolution endovaginal ultrasonography of the endometrium: A noninvasive test for endometrial adequacy. Obstet Gynecol. 1991;78:200–4. Available from: https://pubmed.ncbi.nlm.nih.gov/2067763/
  22. Bonilla-Musoles F, Raga F, Osborne NG, Castillo JC, Bonilla F Jr. Endometrial receptivity: Evaluation with ultrasound. Ultrasound Q. 2013;29:3–20. Available from: https://doi.org/10.1097/ruq.0b013e318281b60a
  23. Richter KS, Bugge KR, Bromer JG, Levy MJ. Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. Fertil Steril. 2007;87(1):53-59. Available from: https://doi.org/10.1016/j.fertnstert.2006.05.064
  24. Takasaki A, Tamura H, Miwa I, Taketani T, Shimamura K, Sugino N. Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertil Steril. 2010;93(6):1851-1858. Available from: https://doi.org/10.1016/j.fertnstert.2008.12.062
  25. Ng EH, Yeung WS, Ho PC. Endometrial and subendometrial vascularity are significantly lower in patients with endometrial volume 2.5 ml or less. Reprod Biomed Online. 2009;18:262–268. Available from: https://doi.org/10.1016/s1472-6483(10)60264-7
  26. Malhotra N, Malhotra J, Malhotra N, Rao JP, Mishra N. Endometrial receptivity and scoring for prediction of implantation and newer markers. Donald Sch J Ultrasound Obstet Gynecol. 2010;4(4):439–446. Available from: https://www.dsjuog.com/doi/pdf/10.5005/jp-journals-10009-1164
  27. Bassil S, Magritte JP, Roth J, Nisolle M, Donnez J, Gordts S. Uterine vascularity during stimulation and its correlation with implantation in in-vitro fertilization. Hum Reprod. 1995;10:1497–1501. Available from: https://doi.org/10.1093/humrep/10.6.1497
  28. Hsieh YY, Chang FC, Tsai HD. Doppler evaluation of the uterine and spiral arteries from different sampling sites and phases of the menstrual cycle during the controlled ovarian hyperstimulation. Ultrasound Obstet Gynecol. pp. 192–196. Available from: https://doi.org/10.1046/j.1469-0705.2000.00196.x
  29. Jarvela IY, Sladkevicius P, Kelly S, Ojha K, Campbell S, Nargund G. Evaluation of endometrial receptivity during in-vitro fertilization using three-dimensional power Doppler ultrasound. Ultrasound Obstet Gynecol. 2005;26:765–769. Available from: https://doi.org/10.1002/uog.2628
  30. Ng EH, Chan CC, Tang OS, Yeung WS, Ho PC. The role of endometrial and subendometrial blood flows measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during IVF treatment. Human Reprod. 2006;21:164–170. Available from: https://doi.org/10.1093/humrep/dei277
  31. Engmann L, Sladkevicius P, Agrawal R, Bekir J, Campbell S, Tan SL. The pattern of changes in ovarian stromal and uterine artery blood flow velocities during IVF treatment and its relationship with outcome of the cycle. Ultrasound Obstet Gynecol. 1999;13:26–33. Available from: https://doi.org/10.1046/j.1469-0705.1999.13010026.x
  32. Dechaud H, Bessueille E, Bousquet PJ, Reyftmann L, Hamamah S, Hedon B. Optimal timing of ultrasonographic and Doppler evaluation of uterine receptivity to implantation. Reprod Biomed Online. 2008;16:368–375. Available from: https://doi.org/10.1016/s1472-6483(10)60598-6
  33. Lesny P, Killick SR, Tetlow RL, Manton DJ, Robinson J, Maguiness SD. Ultrasound evaluation of the uterine zonal anatomy during in-vitro fertilization and embryo transfer. Hum Reprod. 1999;14:1593–1598. Available from: https://doi.org/10.1093/humrep/14.6.1593
  34. Dickey RP, Olar TT, Curole DN, Taylor SN, Rye PH. Endometrial pattern and thickness associated with pregnancy outcome after assisted reproduction technologies. Hum Reprod. 1992;7(3):418-421. Available from: https://doi.org/10.1093/oxfordjournals.humrep.a137661
  35. Smith SK. Angiogenesis and implantation. Hum Reprod. 2000;15 Suppl 6:59-66.
  36. Gargett CE, Rogers PA. Human endometrial angiogenesis. Reproduction. 2001;121(2):181-186. Available from: https://doi.org/10.1530/rep.0.1210181
  37. Shimizu T, Jiang JY, Sasada H, Sato E. Changes of messenger RNA expression of angiogenic factors and related receptors during follicular development in gilts. Biol Reprod. 2002;67(6):1846-1852. Available from: https://doi.org/10.1095/biolreprod.102.006734
  38. Sugino N, Kashida S, Karube-Harada A, Takiguchi S, Kato H. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction. 2002;123(3):379-387. Available from: https://doi.org/10.1530/rep.0.1230379
  39. Matsuoka-Sakata A, Tamura H, Asada H, Miwa I, Taketani T, Yamagata Y, et al. Changes in vascular leakage and expression of angiopoietins in the corpus luteum during pregnancy in rats. Reproduction. 2006;131(2):351-360. Available from: https://doi.org/10.1530/rep.1.00947
  40. Kashida S, Sugino N, Takiguchi S, Karube A, Takayama H, Yamagata Y, et al. Regulation and role of vascular endothelial growth factor in the corpus luteum during mid-pregnancy in rats. Biol Reprod. 2001;64(1):317-323. Available from: https://doi.org/10.1095/biolreprod64.1.317
  41. Sharkey AM, Day K, McPherson A, Malik S, Licence D, Smith SK, et al. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab. 2000;85(1):402-409. Available from: https://doi.org/10.1210/jcem.85.1.6229
  42. Goodman C, Jeyendran RS, Coulam CB. P53 tumor suppressor factor, plasminogen activator inhibitor, and vascular endothelial growth factor gene polymorphisms and recurrent implantation failure. Fertil Steril. 2009;92(2):494-498. Available from: https://doi.org/10.1016/j.fertnstert.2008.07.022
  43. Young SL. Oestrogen and progesterone action on endometrium: a translational approach to understanding endometrial receptivity. Reprod Biomed Online. 2013;27(5):497-505. Available from: https://doi.org/10.1016/j.rbmo.2013.06.010
  44. Garcia-Velasco JA, Acevedo B, Alvarez C, Alvarez M, Bellver J, Fontes J, et al. Strategies to manage refractory endometrium: state of the art in 201. Reprod Biomed Online. 2016;32(5):474-489. Available from: https://doi.org/10.1016/j.rbmo.2016.02.001
  45. Chen MJ, Yang JH, Peng FH, Chen SU, Ho HN, Yang YS. Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs. J Assist Reprod Genet. 2006;23(7–8):337-342. Available from: https://doi.org/10.1007/s10815-006-9053-1
  46. Shen MS, Wang CW, Chen CH, Tzeng CR. New horizon on successful management for a woman with repeated implantation failure due to unresponsive thin endometrium: use of extended estrogen supplementation. J Obstet Gynaecol Res. 2013;39(5):1092-1094. Available from: https://doi.org/10.1111/j.1447-0756.2012.02070.x
  47. Demir B, Dilbaz S, Cinar O, Ozdegirmenci O, Dede S, Dundar B, et al. Estradiol supplementation in intracytoplasmic sperm injection cycles with thin endometrium. Gynecol Endocrinol. 2013;29(1):42-45. Available from: https://doi.org/10.3109/09513590.2012.705381
  48. Torres RF, Habana AE, Tansengco LG. The effect of estrogen supplementation on the endometrium and pregnancy rate among infertile women treated with clomifene citrate: a meta-analysis. Fertil Steril. 2005;84:S162-S163. Available from: http://dx.doi.org/10.1016/j.fertnstert.2005.07.399
  49. Cetinkaya K, Kadanali S. The effect of administering vaginal estrogen to clomiphene citrate stimulated cycles on endometrial thickness and pregnancy rates in unexplained infertility. J Turk Ger Gynecol Assoc. 2012;13(3):157-161. Available from: https://doi.org/10.5152/jtgga.2012.20
  50. Tourgeman DE, Slater CC, Stanczyk FZ, Paulson RJ. Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil Steril. 2001;75(1):200-202. Available from: https://doi.org/10.1016/s0015-0282(00)01640-x
  51. Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril. 1997;68(5):927-930. Available from: https://doi.org/10.1016/s0015-0282(97)00330-0
  52. Wada I, Hsu CC, Williams G, Macnamee MC, Brinsden PR. The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Hum Reprod. 1994;9:1954–1957. Available from: https://doi.org/10.1093/oxfordjournals.humrep.a138366
  53. Kuo HC, Hsu CC, Wang ST, Huang KE. Aspirin improves uterine blood flow in the peri-implantation period. J Formos Med Assoc. 1997;96(4):253-257. Available from: https://pubmed.ncbi.nlm.nih.gov/9136511/
  54. Hurst BS, Bhojwani JT, Marshburn PB, Papadakis MA, Loeb TA, Matthews ML. Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization. J Exp Clin Assist Reprod. 2005;2:8. Available from: https://doi.org/10.1186/1743-1050-2-8
  55. Urman B, Mercan R, Alatas C, Balaban B, Isiklar A, Nuhoglu A. Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study. J Assist Reprod Genet. 2000;17(10):586-590. Available from: https://doi.org/10.1023/a:1026491426423
  56. Sher G, Fisch JD. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril. 2002;78(5):1073-1076. Available from: https://doi.org/10.1016/s0015-0282(02)03375-7
  57. Sher G, Fisch JD. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod. 2000;15(4):806-809. Available from: https://doi.org/10.1093/humrep/15.4.806
  58. Di X, Gennings C, Bear HD, Graham LJ, Sheth CM, White KL Jr, et al. Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells. Breast Cancer Res Treat. 2010;124(2):349-360. Available from: https://doi.org/10.1007/s10549-010-0765-7
  59. Fetih AN, Habib DM, Abdelaal II, Hussein M, Fetih GN, Othman ER. Adding sildenafil vaginal gel to clomiphene citrate in infertile women with prior clomiphene citrate failure due to thin endometrium: a prospective self-controlled clinical trial. Facts Views Vis Obgyn. 2017;9(1):21-27. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5506766/
  60. Zinger M, Liu JH, Thomas MA. Successful use of vaginal sildenafil citrate in two infertility patients with Asherman's syndrome. J Womens Health (Larchmt). 2006;15(4):442-444. Available from: https://doi.org/10.1089/jwh.2006.15.442
  61. Dehghani Firouzabadi R, Davar R, Hojjat F, Mahdavi M. Effect of sildenafil citrate on endometrial preparation and outcome of frozen-thawed embryo transfer cycles: a randomized clinical trial. Iran J Reprod Med. 2013;11(2):151-158. Available from: https://pubmed.ncbi.nlm.nih.gov/24639741/
  62. Pyriochou A, Zhou Z, Koika V, Petrou C, Cordopatis P, Sessa WC, et al. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway. J Cell Physiol. 2007 Apr;211(1):197-204. Available from: https://doi.org/10.1002/jcp.20929
  63. Eftekhar M, Rahmani E, Pourmasumi S. Evaluation of clinical factors influencing pregnancy rate in frozen embryo transfer. Iran J Reprod Med. 2014;12(7):513-518. Available from: https://pubmed.ncbi.nlm.nih.gov/25114675/
  64. LedeeBataille N, Olivennes F, Lefaix JL, Chaouat G, Frydman R, Delanian S. Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Hum Reprod. 2002;17(5):1249-53. Available from: https://doi.org/10.1093/humrep/17.5.1249
  65. Acharya S, Yasmin E, Balen AH. The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies–a report of 20 cases. Hum Fertil (Camb). 2009;12(4):198-203. Available from: https://doi.org/10.3109/14647270903377178
  66. Cicek N, Eryilmaz OG, Sarikaya E, Gulerman C, Genc Y. Vitamin E effect on controlled ovarian stimulation of unexplained infertile women. J Assist Reprod Genet. 2012;29(4):325-328. Available from: https://doi.org/10.1007/s10815-012-9714-1
  67. Chiao TB, Lee AJ. Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis. Ann Pharmacother. 2005;39(3):516-522. Available from: https://doi.org/10.1345/aph.1e186
  68. Zackrisson U, Brannstrom M, Granberg S, Janson PO, Collins WP, Bourne TH. Acute effects of a transdermal nitric oxide donor on perifollicular and intrauterine blood flow. Ultrasound Obstet Gynecol. 1998;12(1):50-55. Available from: https://doi.org/10.1046/j.1469-0705.1998.12010050.x
  69. Ohl J, Lefebvre Maunoury C, Wittemer C, Nisand G, Laurent MC, Hoffmann P. Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial. Hum Reprod. 2002;17(10):2615-2620. Available from: https://doi.org/10.1093/humrep/17.10.2615
  70. Reynolds K, Khoury J, Sosnowski J, Thie J, Hofmann G. Comparison of the effect of tamoxifen on endometrial thickness in women with thin endometrium (<7 mm) undergoing ovulation induction with clomiphene citrate. Fertil Steril. 2010;93(6):2091-2093. Available from: https://doi.org/10.1016/j.fertnstert.2009.08.038
  71. Ke H, Jiang J, Xia M, Tang R, Qin Y, Chen ZJ. The effect of tamoxifen on thin endometrium in patients undergoing frozen-thawed embryo transfer. Reprod Sci. 2018 Jun;25(6):861-866. Available from: https://doi.org/10.1177/1933719117698580
  72. Licht P, Fluhr H, Neuwinger J, Wallwiener D, Wildt L. Is human chorionic gonadotropin directly involved in the regulation of human implantation? Mol Cell Endocrinol. 2007;269(1–2):85-92. Available from: https://doi.org/10.1016/j.mce.2006.09.016
  73. Eftekhar M, Rahmani E, Eftekhar T. Effect of adding human chorionic gonadotropin to the endometrial preparation protocol in frozen embryo transfer cycles. Int J Fertil Steril. 2012;6(3):175-176. Available from: https://pubmed.ncbi.nlm.nih.gov/24520435/
  74. Papanikolaou EG, Kyrou D, Zervakakou G, Paggou E, Humaidan P. Follicular HCG endometrium priming for IVF patients experiencing resisting thin endometrium. A proof of concept study. J Assist Reprod Genet. 2013;30(10):1341-1345. Available from: https://doi.org/10.1007/s10815-013-0076-0
  75. Davar R, Miraj S, Mojtahedi M. Farid. Effect of adding human chorionic gonadotropin to frozen thawed embryo transfer cycles with history of thin endometrium. Int J Reprod Biomed (Yazd). 2016;14(1):53-56. Available from: https://pubmed.ncbi.nlm.nih.gov/27141549/
  76. Wang CW, Horng SG, Chen CK, Wang HS, Huang HY, Lee CL, et al. Ovulation induction with tamoxifen and alternate-day gonadotrophin in patients with thin endometrium. Reprod Biomed Online. 2008;17(1):20-26. Available from: https://doi.org/10.1016/s1472-6483(10)60288-x
  77. Eftekhar M, Hosseinisadat R, Baradaran R, Naghshineh E. Effect of granulocyte colony stimulating factor (G-CSF) on IVF outcomes in infertile women: an RCT. Int J Reprod Biomed (Yazd). 2016;14(5):341-346. Available from: https://pubmed.ncbi.nlm.nih.gov/27326420/
  78. Tehraninejad E, Davari Tanha F, Asadi E, Kamali K, Aziminikoo E, Rezayof E. G-CSF Intrauterine for thin endometrium, and pregnancy outcome. J Family Reprod Health. 2015;9(3):107-112. Available from: https://pubmed.ncbi.nlm.nih.gov/26622308/
  79. Zenclussen AC, Hammerling GJ. Cellular regulation of the uterine microenvironment that enables embryo implantation. Front Immunol. 2015;6:321. Available from: https://doi.org/10.3389/fimmu.2015.00321
  80. Wurfel W, Santjohanser C, Hirv K, Buhl M, Meri O, Laubert I, et al. High pregnancy rates with administration of granulocyte colony-stimulating factor in ART-patients with repetitive implantation failure and lacking killer-cell immunglobulin-like receptors. Hum Reprod. 2010;25(8):2151-2152 author reply 2152. Available from: https://doi.org/10.1093/humrep/deq106
  81. Gleicher N, Vidali A, Barad DH. Successful treatment of unresponsive thin endometrium. Fertil Steril. 2011;95(6):2123.e13-7. Available from: https://doi.org/10.1016/j.fertnstert.2011.01.143
  82. Barad DH, Yu Y, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, et al. A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates. Fertil Steril. 2014;101(3):710-5. Available from: https://doi.org/10.1016/j.fertnstert.2013.12.016
  83. Eftekhar M, Sayadi M, Arabjahvani F. Transvaginal perfusion of G-CSF for infertile women with thin endometrium in frozen ET program: a non-randomized clinical trial. Iran J Reprod Med. 2014;12(10):661-6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4248151/
  84. Li Y, Pan P, Chen X, Li L, Li Y, Yang D. Granulocyte colony-stimulating factor administration for infertile women with thin endometrium in frozen embryo transfer program. Reprod Sci. 2014;21(3):381-5. Available from: https://doi.org/10.1177/1933719113497286
  85. Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Correa do Amaral RJ, Granjeiro JM, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4(3):67. Available from: https://doi.org/10.1186/scrt218
  86. Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, et al. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med. 2015;8(1):1286-90. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4358582/
  87. Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, Messelink EJ, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2010;57(1):35-48. Available from: https://doi.org/10.1016/j.eururo.2009.08.020
  88. Bodombossou-Djobo MM, Zheng C, Chen S, Yang D. Neuromuscular electrical stimulation and biofeedback therapy may improve endometrial growth for patients with thin endometrium during frozen-thawed embryo transfer: a preliminary report. Reprod Biol Endocrinol. 2011;9:122. Available from: https://doi.org/10.1186/1477-7827-9-122
  89. Zadehmodarres S, Salehpour S, Saharkhiz N, Nazari L. Treatment of thin endometrium with autologous platelet-rich plasma: a pilot study. JBRA Assist Reprod. 2017;21(1):54-6. Available from: https://doi.org/10.5935/1518-0557.20170013
  90. Gargett CE. Uterine stem cells: what is the evidence? Hum Reprod Update. 2007;13(1):87-101. Available from: https://doi.org/10.1093/humupd/dml045
  91. Cervello I, Mas A, Gil-Sanchis C, Peris L, Faus A, Saunders PT, et al. Reconstruction of endometrium from human endometrial side population cell lines. PLoS One. 2011;6(6):e21221. Available from: https://doi.org/10.1371/journal.pone.0021221
  92. Zhao J, Zhang Q, Wang Y, Li Y. Uterine infusion with bone marrow mesenchymal stem cells improves endometrium thickness in a rat model of thin endometrium. Reprod Sci. 2015;22(2):181-8. Available from: https://doi.org/10.1177/1933719114537715
  93. Jing Z, Qiong Z, Yonggang W, Yanping L. Rat bone marrow mesenchymal stem cells improve regeneration of thin endometrium in rat. Fertil Steril. 2014;101(2):587-94. Available from: https://doi.org/10.1016/j.fertnstert.2013.10.053
  94. Taylor HS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA. 2004;292(1):81-5. Available from: https://doi.org/10.1001/jama.292.1.81
  95. Du H, Taylor HS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells. 2007;25(8):2082-6. Available from: https://doi.org/10.1634/stemcells.2006-0828
  96. Ikoma T, Kyo S, Maida Y, Ozaki S, Takakura M, Nakao S, et al. Bone marrow-derived cells from male donors can compose endometrial glands in female transplant recipients. Am J Obstet Gynecol. 2009;201(6):608.e1-8. Available from: https://doi.org/10.1016/j.ajog.2009.07.026
  97. Morelli SS, Rameshwar P, Goldsmith LT. Experimental evidence for bone marrow as a source of nonhematopoietic endometrial stromal and epithelial compartment cells in a murine model. Biol Reprod. 2013;89(1):7. Available from: https://doi.org/10.1095/biolreprod.113.107987
  98. Hunter RK 2nd, Nevitt CD, Gaskins JT, Keller BB, Bohler HC Jr, LeBlanc AJ. Adipose-derived stromal vascular fraction cell effects on a rodent model of thin endometrium. PLoS One. 2015;10(12):e0144823. Available from: https://doi.org/10.1371/journal.pone.0144823
  99. Alawadhi F, Du H, Cakmak H, Taylor HS. Bone marrow-derived stem cell (BMDSC) transplantation improves fertility in a murine model of Asherman's syndrome. PLoS One. 2014;9(5):e96662. Available from: https://doi.org/10.1371/journal.pone.0096662
  100. Kilic S, Yuksel B, Pinarli F, Albayrak A, Boztok B, Delibasi T. Effect of stem cell application on Asherman syndrome, an experimental rat model. J Assist Reprod Genet. 2014;31(8):975-82. Available from: https://doi.org/10.1007/s10815-014-0268-2
  101. Gil-Sanchis C, Cervello I, Khurana S, Faus A, Verfaillie C, Simon C. Contribution of different bone marrow-derived cell types in endometrial regeneration using an irradiated murine model. Fertil Steril. 2015;103(6):1596-605.e1. Available from: https://doi.org/10.1016/j.fertnstert.2015.02.030
  102. Nagori CB, Panchal SY, Patel H. Endometrial regeneration using autologous adult stem cells followed by conception by in vitro fertilization in a patient of severe Asherman's syndrome. J Hum Reprod Sci. 2011;4(1):43-8. Available from: https://doi.org/10.4103/0974-1208.82360
  103. Singh N, Mohanty S, Seth T, Shankar M, Bhaskaran S, Dharmendra S. Autologous stem cell transplantation in refractory Asherman's syndrome: a novel cell based therapy. J Hum Reprod Sci. 2014;7(2):93-8. Available from: https://doi.org/10.4103/0974-1208.138864
  104. Santamaria X, Cabanillas S, Cervello I, Arbona C, Raga F, Ferro J, et al. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod. 2016;31(5):1087-96. Available from: https://doi.org/10.1093/humrep/dew042
  105. Schlaff WD, Hurst BS. Preoperative sonographic measurement of endometrial pattern predicts outcome of surgical repair in patients with severe Asherman's syndrome. Fertil Steril. 1995;63(2):410-3. Available from: https://doi.org/10.1016/s0015-0282(16)57379-8
  106. Jimenez PT, Schon SB, Odem RR, Ratts VS, Jungheim ES. A retrospective cross-sectional study: fresh cycle endometrial thickness is a sensitive predictor of inadequate endometrial thickness in frozen embryo transfer cycles. Reprod Biol Endocrinol. 2013;11:35. Available from: https://doi.org/10.1186/1477-7827-11-35
  107. Qublan H, Amarin Z, Al-Qudah M, Diab F, Nawasreh M, Malkawi S, et al. Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of ≤7 mm on day of egg retrieval. Hum Fertil (Camb). 2008;11(1):43-7. Available from: https://doi.org/10.1080/14647270701704768
  108. Garrido-Gomez T, Ruiz-Alonso M, Blesa D, Diaz-Gimeno P, Vilella F, Simon C. Profiling the gene signature of endometrial receptivity: clinical results. Fertil Steril. 2013;99(4):1078-85. Available from: https://doi.org/10.1016/j.fertnstert.2012.12.005
  109. Diaz-Gimeno P, Horcajadas JA, Martinez-Conejero JA, Esteban FJ, Alama P, Pellicer A, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011;95(1):50-60.e1-15. Available from: https://doi.org/10.1016/j.fertnstert.2010.04.063
  110. Cruz F, Bellver J. Live birth after embryo transfer in an unresponsive thin endometrium. Gynecol Endocrinol. 2014;30(7):481-4. Available from: https://doi.org/10.3109/09513590.2014.900747
  111. Gargett CE, Nguyen HP, Ye L. Endometrial regeneration and endometrial stem/progenitor cells. Rev Endocr Metab Disord. 2012;13(4):235-51. Available from: https://doi.org/10.1007/s11154-012-9221-9
  112. Du H, Naqvi H, Taylor HS. Ischemia/reperfusion injury promotes and granulocyte-colony stimulating factor inhibits migration of bone marrow-derived stem cells to endometrium. Stem Cells Dev. 2012;21(18):3324-31. Available from: https://doi.org/10.1089/scd.2011.0193
  113. Cervello I, Gil-Sanchis C, Mas A, Faus A, Sanz J, Moscardo F, et al. Bone marrow-derived cells from male donors do not contribute to the endometrial side population of the recipient. PLoS One. 2012;7(1):e30260. Available from: https://doi.org/10.1371/journal.pone.0030260
  114. Issacs JD, Wells CS, William DB, Odem RR, Gast MJ, Strickler RC. Endometrial thickness is a valid monitoring parameter in cycles of ovulation induction with menotropins alone. Fertil Steril. 1996;65:262-6. Available from: https://doi.org/10.1016/s0015-0282(16)58082-0
  115. Check JH, Dietterich C, Lurie D, Nazari A, Chuong J. A matched study to determine whether low-dose aspirin without heparin improves pregnancy rates following frozen embryo transfer and/or affects endometrial sonographic parameters. J Assist Reprod Genet. 1998;15(10):579-82. Available from: https://doi.org/10.1023/a:1020373009043
  116. Check JH, Nowroozi K, Choe J, Dietterich C. Influence of endometrial thickness and echo patterns on pregnancy rates during in vitro fertilization. Fertil Steril. 1991;56(6):1173-5. Available from: https://doi.org/10.1016/s0015-0282(16)54736-0
  117. Bedaiwy MA, Abdelaleem MA, Hussein M, Mousa N, Brunengraber LN, Casper RF. Hormonal, follicular and endometrial dynamics in letrozole-treated versus natural cycles in patients undergoing controlled ovarian stimulation. Reprod Biol Endocrinol. 2011;9:83. Available from: https://doi.org/10.1186/1477-7827-9-83
  118. Gleicher N, Kim A, Michaeli T, Lee HJ, Shohat-Tal A, Lazzaroni E, et al. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum Reprod. 2013;28(1):172-7. Available from: https://doi.org/10.1093/humrep/des370
  119. Lebovitz O, Orvieto R. Treating patients with “thin” endometrium - an ongoing challenge. Gynecol Endocrinol. 2014;30(6):409-14. Available from: https://doi.org/10.3109/09513590.2014.906571
  120. Kovacs P, Matyas S, Boda K, Kaali SG. The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod. 2003;18(11):2337-41. Available from: https://doi.org/10.1093/humrep/deg461
  121. Gelbaya TA, Kyrgiou M, Li TC, Stern C, Nardo LG. Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2007;13(4):357-64. Available from: https://doi.org/10.1093/humupd/dmm005

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Figure 1

Figure 5

Figure 1

Figure 6

Figure 1

Figure 7

Figure 1

Figure 8

Figure 1

Figure 9

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?